ACER THERAPEUTICS INC's ticker is and the CUSIP is 00444P908. A total of 1 filers reported holding ACER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,100 | +57.1% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 700 | -87.9% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 5,800 | +132.0% | 0.00% | – |
| Q1 2022 | $7,000 | – | 2,500 | +525.0% | 0.00% | – |
| Q4 2021 | $0 | – | 400 | +100.0% | 0.00% | – |
| Q3 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 200 | +19900.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |